2 completed, 1 terminated. 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow David Antoniucci: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? ) Ticagrelor mashed pills, Ticagrelor integral pills - Acute Coronary Syndrome, Adverse Reaction to Antiplatelet Agent | Phase 3 | Completed | David Antoniucci | 82 | 2013-11-01 | 2015-03-17 |
| Rapid Activity of Platelet Inhibitor Drugs Study 2 Prasugrel, Ticagrelor - Myocardial Infarction | Phase 4 | Completed | David Antoniucci | 50 | 2012-11-01 | 2014-09-25 |
| BLeeding Events and Maintenance DoSe of PraSugrel Prasugrel dose 5 mg/day, Prasugrel dose 10 mg/day - Adverse Reaction to Antiplatelet Agent, Acute Coronary Syndrome | Phase 4 | Terminated | David Antoniucci | 195 | 2012-11-01 | 2016-07-29 |
Acute Coronary Syndrome (2) · Myocardial Infarction (1)
Prasugrel Hydrochloride (1) · Ticagrelor (1)
Italy (3) · Greece (1)
Guido Parodi, MD (1)